VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q85578739 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010855.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q85578739‏
024 ‎‡a 0000-0003-4612-3236‏ ‎‡2 orcid‏
024 ‎‡a 55626148800‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q85578739‏
100 0 ‎‡a Marcos Avila-Rodriguez‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Marcos Avila-Rodriguez‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions.‏
670 ‎‡a Author's Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia.‏
670 ‎‡a Author's Application of Acyzol in the Context of Zinc Deficiency and Perspectives.‏
670 ‎‡a Author's Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome.‏
670 ‎‡a Author's Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status‏
670 ‎‡a Author's Copper and Neurotoxicity in Autism Spectrum Disorder‏
670 ‎‡a Author's Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor‏
670 ‎‡a Author's Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?‏
670 ‎‡a Author's Medicinal plants as protective strategies against Parkinson's Disease.‏
670 ‎‡a Author's Microglial dependent protective effects of neuroactive steroids.‏
670 ‎‡a Author's Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer Disease‏
670 ‎‡a Author's Nanotechnology for Alzheimer Disease.‏
670 ‎‡a Author's Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review‏
670 ‎‡a Author's Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system.‏
670 ‎‡a Author's Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder.‏
670 ‎‡a Author's Protection by Neuroglobin Expression in Brain Pathologies‏
670 ‎‡a Author's Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics‏
670 ‎‡a Author's Sleep Disorders Associated With Alzheimer's Disease: A Perspective.‏
670 ‎‡a Author's Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression‏
670 ‎‡a Author's Tibolone protects T98G cells from glucose deprivation.‏
670 ‎‡a Author's Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta.‏
909 ‎‡a (orcid) 0000000346123236‏ ‎‡9 1‏
909 ‎‡a (scopus) 55626148800‏ ‎‡9 1‏
919 ‎‡a neurophysiologyandpsychopathologyunderlying PTSD andrecentinsightsintothe PTSD therapiesacomprehensivereview‏ ‎‡A Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review‏ ‎‡9 1‏
919 ‎‡a neuroprotectiveeffectsofthecatalyticsubunitoftelomeraseapotentialtherapeutictargetinthecentralnervoussystem‏ ‎‡A Neuroprotective effects of the catalytic subunit of telomerase: A potential therapeutic target in the central nervous system.‏ ‎‡9 1‏
919 ‎‡a advancesinmedicinalplantswitheffectsonanxietybehaviorassociatedtomentalandhealthconditions‏ ‎‡A Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions.‏ ‎‡9 1‏
919 ‎‡a alterationsinglucosemetabolismoncognitionapossiblelinkbetweendiabetesanddementia‏ ‎‡A Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia.‏ ‎‡9 1‏
919 ‎‡a applicationofacyzolinthecontextofzincdeficiencyandperspectives‏ ‎‡A Application of Acyzol in the Context of Zinc Deficiency and Perspectives.‏ ‎‡9 1‏
919 ‎‡a approachesforthedevelopmentofdrugsfortreatmentofobesityandmetabolicsyndrome‏ ‎‡A Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome.‏ ‎‡9 1‏
919 ‎‡a canmirnasbeconsideredasdiagnosticandtherapeuticmoleculesinischemicstrokepathogenesiscurrentstatus‏ ‎‡A Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?-Current Status‏ ‎‡9 1‏
919 ‎‡a copperandneurotoxicityinautismspectrumdisorder‏ ‎‡A Copper and Neurotoxicity in Autism Spectrum Disorder‏ ‎‡9 1‏
919 ‎‡a growthfactorsandastrocytesmetabolismpossiblerolesforplateletderivedgrowthfactor‏ ‎‡A Growth Factors and Astrocytes Metabolism: Possible Roles for Platelet Derived Growth Factor‏ ‎‡9 1‏
919 ‎‡a tibolonereducesoxidativedamageandinflammationinmicrogliastimulatedwithpalmiticacidthroughmechanismsinvolvingestrogenreceptorbeta‏ ‎‡A Tibolone Reduces Oxidative Damage and Inflammation in Microglia Stimulated with Palmitic Acid through Mechanisms Involving Estrogen Receptor Beta.‏ ‎‡9 1‏
919 ‎‡a tiboloneprotectst98gcellsfromglucosedeprivation‏ ‎‡A Tibolone protects T98G cells from glucose deprivation.‏ ‎‡9 1‏
919 ‎‡a isvegfakeytargetofcotinineandotherpotentialtherapiesagainstalzheimerdisease‏ ‎‡A Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?‏ ‎‡9 1‏
919 ‎‡a tiboloneprotectsastrocyticcellsfromglucosedeprivationthroughamechanisminvolvingestrogenreceptorbetaandtheupregulationofneuroglobinexpression‏ ‎‡A Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression‏ ‎‡9 1‏
919 ‎‡a medicinalplantsasprotectivestrategiesagainstparkinsonsdisease‏ ‎‡A Medicinal plants as protective strategies against Parkinson's Disease.‏ ‎‡9 1‏
919 ‎‡a sleepdisordersassociatedwithalzheimersdiseaseaperspective‏ ‎‡A Sleep Disorders Associated With Alzheimer's Disease: A Perspective.‏ ‎‡9 1‏
919 ‎‡a microglialdependentprotectiveeffectsofneuroactivesteroids‏ ‎‡A Microglial dependent protective effects of neuroactive steroids.‏ ‎‡9 1‏
919 ‎‡a sexdifferencesinparkinsonsdiseasefeaturesonclinicalsymptomstreatmentoutcomesexualhormonesandgenetics‏ ‎‡A Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics‏ ‎‡9 1‏
919 ‎‡a mitochondrialpermeabilitytransitionporeasasuitabletargetforneuroprotectiveagentsagainstalzheimerdisease‏ ‎‡A Mitochondrial Permeability Transition Pore as a Suitable Target for Neuroprotective Agents Against Alzheimer Disease‏ ‎‡9 1‏
919 ‎‡a protectionbyneuroglobinexpressioninbrainpathologies‏ ‎‡A Protection by Neuroglobin Expression in Brain Pathologies‏ ‎‡9 1‏
919 ‎‡a nanotechnologyforalzheimerdisease‏ ‎‡A Nanotechnology for Alzheimer Disease.‏ ‎‡9 1‏
919 ‎‡a nicotinederivedcompoundsastherapeutictoolsagainstposttraumaticstressdisorder‏ ‎‡A Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder.‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000396187481
996 ‎‡2 DNB|1057068004
996 ‎‡2 LC|n 85057857
996 ‎‡2 LC|n 2010026176
996 ‎‡2 PTBNP|1591076
996 ‎‡2 LC|no2007146083
996 ‎‡2 NII|DA16082274
996 ‎‡2 DNB|131877844
996 ‎‡2 LC|nb2019022234
996 ‎‡2 LC|n 78098235
996 ‎‡2 J9U|987007361192205171
996 ‎‡2 LC|no2011091315
996 ‎‡2 BNC|981058616864906706
996 ‎‡2 DNB|1057452173
996 ‎‡2 BNE|XX1082751
996 ‎‡2 LC|ns2016000698
996 ‎‡2 DNB|108193882X
996 ‎‡2 BNC|981060918133706706
996 ‎‡2 LC|no2011080900
996 ‎‡2 ISNI|0000000497186250
996 ‎‡2 DNB|107495999X
996 ‎‡2 LC|ns2019000075
996 ‎‡2 LC|no2019073416
996 ‎‡2 LC|no2008128081
996 ‎‡2 BNE|XX842274
996 ‎‡2 DNB|1061304213
996 ‎‡2 DNB|1057592870
996 ‎‡2 BNE|XX1554480
996 ‎‡2 LC|no 00030536
996 ‎‡2 BNE|XX1652163
996 ‎‡2 SUDOC|07470446X
996 ‎‡2 BIBSYS|90688593
996 ‎‡2 ISNI|0000000038121466
996 ‎‡2 ISNI|0000000060533280
996 ‎‡2 DNB|141068892
996 ‎‡2 BNCHL|10000000000000000803120
996 ‎‡2 LC|ns2013002739
996 ‎‡2 DNB|101532665X
996 ‎‡2 SUDOC|085871893
996 ‎‡2 SUDOC|161693040
996 ‎‡2 LC|no2007064497
996 ‎‡2 SUDOC|223551996
996 ‎‡2 PLWABN|9810629392405606
996 ‎‡2 BNE|XX5398172
996 ‎‡2 SUDOC|226958809
996 ‎‡2 BNC|981061046571406706
996 ‎‡2 BLBNB|000336088
996 ‎‡2 BNCHL|10000000000000000271825
996 ‎‡2 BNCHL|10000000000000000839160
996 ‎‡2 LC|no2022119029
996 ‎‡2 BNF|12263448
996 ‎‡2 LC|n 2022024365
996 ‎‡2 ISNI|0000000119467872
996 ‎‡2 NLA|000035238299
996 ‎‡2 LC|n 85225155
996 ‎‡2 LC|ns2018000453
996 ‎‡2 RERO|A018919324
996 ‎‡2 J9U|987007335616005171
996 ‎‡2 BNF|15719522
996 ‎‡2 ISNI|0000000400555479
996 ‎‡2 SUDOC|116316292
996 ‎‡2 ISNI|0000000432059955
996 ‎‡2 LC|no2016125641
996 ‎‡2 LC|no2003115646
996 ‎‡2 ISNI|0000000078733803
996 ‎‡2 SUDOC|245410228
996 ‎‡2 ISNI|0000000059242806
996 ‎‡2 BNE|XX1630605
996 ‎‡2 LC|no2006099962
996 ‎‡2 ISNI|0000000051254685
996 ‎‡2 ISNI|0000000108185538
996 ‎‡2 SUDOC|256012717
996 ‎‡2 LC|n 2008056890
996 ‎‡2 CAOONL|ncf10323044
996 ‎‡2 BNC|981058507650606706
996 ‎‡2 LC|no 97031938
996 ‎‡2 PTBNP|1466929
996 ‎‡2 LC|no2020029734
996 ‎‡2 SUDOC|117857734
996 ‎‡2 BNE|XX1768164
996 ‎‡2 NUKAT|n 99041890
996 ‎‡2 NUKAT|n 2017075764
996 ‎‡2 BNC|981060554271806706
996 ‎‡2 ISNI|0000000078243935
996 ‎‡2 BIBSYS|90905400
996 ‎‡2 PLWABN|9814001217405606
996 ‎‡2 B2Q|0001205354
996 ‎‡2 ISNI|0000000029029780
996 ‎‡2 BNE|XX5267530
996 ‎‡2 BNE|XX5542221
996 ‎‡2 ISNI|0000000078065446
996 ‎‡2 NTA|344550680
996 ‎‡2 LC|n 84104399
996 ‎‡2 LC|n 98026541
996 ‎‡2 NTA|298791234
996 ‎‡2 BNC|981058611000706706
996 ‎‡2 J9U|987007339973105171
996 ‎‡2 CAOONL|ncf10177356
996 ‎‡2 LC|no2021117063
996 ‎‡2 LC|ns2023002636
996 ‎‡2 DNB|170697541
996 ‎‡2 BNE|XX5700754
996 ‎‡2 LC|ns2024002920
996 ‎‡2 BNC|981058525515806706
996 ‎‡2 DNB|1163816590
996 ‎‡2 BNCHL|10000000000000000126596
996 ‎‡2 BNE|XX5118342
996 ‎‡2 LC|n 2001087821
996 ‎‡2 ISNI|0000000036299228
996 ‎‡2 ISNI|0000000000986245
996 ‎‡2 ISNI|0000000053683301
996 ‎‡2 DNB|171708067
996 ‎‡2 BNC|981058608765606706
996 ‎‡2 LC|ns2014000190
996 ‎‡2 ISNI|000000037186612X
996 ‎‡2 ISNI|000000040924620X
996 ‎‡2 PTBNP|1659907
996 ‎‡2 ISNI|0000000051647948
996 ‎‡2 BNCHL|10000000000000000101855
996 ‎‡2 BNF|13558790
996 ‎‡2 BNE|XX1150740
996 ‎‡2 DNB|1064681697
996 ‎‡2 ISNI|0000000454612854
996 ‎‡2 CAOONL|ncf11039556
996 ‎‡2 NSK|000605072
996 ‎‡2 BNCHL|10000000000000000260720
996 ‎‡2 PLWABN|9811511592105606
996 ‎‡2 BNE|XX4917796
996 ‎‡2 ISNI|0000000080826507
996 ‎‡2 ISNI|0000000083649171
996 ‎‡2 BNE|XX920176
996 ‎‡2 PLWABN|9810558772205606
996 ‎‡2 BNCHL|10000000000000000198547
996 ‎‡2 ISNI|0000000060416076
996 ‎‡2 NTA|310376327
996 ‎‡2 RERO|A003754220
996 ‎‡2 LC|ns2020000686
996 ‎‡2 BNE|XX1780717
996 ‎‡2 PLWABN|9810542155505606
996 ‎‡2 ISNI|0000000060779758
996 ‎‡2 SUDOC|11009767X
996 ‎‡2 LC|ns2012000847
996 ‎‡2 BIBSYS|7030694
996 ‎‡2 BNF|16146019
996 ‎‡2 BNE|XX6140434
996 ‎‡2 BNF|13171070
996 ‎‡2 NTA|419255117
996 ‎‡2 LC|no2011081835
996 ‎‡2 SUDOC|074629654
996 ‎‡2 ISNI|0000000031060015
996 ‎‡2 LC|n 2003072735
996 ‎‡2 BNCHL|10000000000000000245732
996 ‎‡2 DNB|130826790
996 ‎‡2 LC|ns2015001088
996 ‎‡2 LC|no2018067548
996 ‎‡2 BNE|XX1644107
996 ‎‡2 ISNI|0000000038021967
996 ‎‡2 LC|ns2019003628
996 ‎‡2 BNE|XX6509118
996 ‎‡2 DNB|1061538397
996 ‎‡2 DNB|1192919912
996 ‎‡2 SUDOC|031416128
996 ‎‡2 LC|no2019115088
996 ‎‡2 RERO|A003754217
996 ‎‡2 SUDOC|187116970
996 ‎‡2 BIBSYS|14028811
996 ‎‡2 DNB|1018427058
996 ‎‡2 LC|n 2004044454
996 ‎‡2 ISNI|0000000418487646
996 ‎‡2 ISNI|0000000050872609
996 ‎‡2 ISNI|0000000120042206
996 ‎‡2 DNB|131678639
996 ‎‡2 LC|no2022137235
996 ‎‡2 DNB|1057051322
996 ‎‡2 ISNI|0000000078835834
996 ‎‡2 SUDOC|104541806
996 ‎‡2 LC|n 97033493
996 ‎‡2 LC|no2024136409
996 ‎‡2 DNB|136204627
996 ‎‡2 LC|no2018025005
996 ‎‡2 BIBSYS|1707990472561
996 ‎‡2 NTA|304110655
996 ‎‡2 ISNI|0000000432954968
996 ‎‡2 DNB|1057271306
996 ‎‡2 DNB|1057277746
996 ‎‡2 NTA|11073470X
996 ‎‡2 ISNI|0000000075438542
996 ‎‡2 LC|no2010200677
996 ‎‡2 DNB|135267277
996 ‎‡2 BLBNB|001500212
996 ‎‡2 BNE|XX5424072
996 ‎‡2 CAOONL|ncf10924331
996 ‎‡2 SUDOC|052499685
996 ‎‡2 LC|no2015148286
996 ‎‡2 LC|no2008076882
996 ‎‡2 ISNI|000000004277155X
996 ‎‡2 ISNI|0000000500593907
996 ‎‡2 ISNI|0000000025879796
996 ‎‡2 ISNI|000000006102404X
996 ‎‡2 ISNI|0000000059964577
996 ‎‡2 ISNI|0000000073781865
996 ‎‡2 DNB|140196501
996 ‎‡2 ISNI|0000000032372395
996 ‎‡2 ISNI|0000000451873709
996 ‎‡2 LC|no2009007539
996 ‎‡2 BNC|981061210707306706
996 ‎‡2 NUKAT|n 2022128112
996 ‎‡2 BNF|12441085
996 ‎‡2 LC|n 86021430
996 ‎‡2 BNE|XX5591989
996 ‎‡2 LC|n 87111428
996 ‎‡2 BNE|XX1542968
996 ‎‡2 LC|n 81104768
996 ‎‡2 LC|no2018172811
996 ‎‡2 ISNI|0000000072176874
996 ‎‡2 LC|no2017036630
996 ‎‡2 LC|no2006075762
996 ‎‡2 ISNI|0000000117567394
996 ‎‡2 BNE|XX6174100
996 ‎‡2 BNE|XX1093477
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏